AMGN Amgen Inc

Price (delayed)

$220.65

Market cap

$117.9B

P/E Ratio

14.9

Dividend/share

$8.14

EPS

$14.81

Enterprise value

$147.93B

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. ...

Highlights
AMGN's quick ratio has surged by 191% year-on-year and by 176% since the previous quarter
Amgen's equity has increased by 46% from the previous quarter
The debt has surged by 67% year-on-year and by 58% since the previous quarter

Key stats

What are the main financial stats of AMGN
Market
Shares outstanding
534.33M
Market cap
$117.9B
Enterprise value
$147.93B
Valuations
Price to book (P/B)
22.03
Price to sales (P/S)
4.5
EV/EBIT
13.74
EV/EBITDA
10.39
EV/Sales
5.65
Earnings
Revenue
$26.19B
EBIT
$10.77B
EBITDA
$14.24B
Free cash flow
$7.53B
Per share
EPS
$14.81
Free cash flow per share
$14.1
Book value per share
$10.02
Revenue per share
$49.04
TBVPS
$108.23
Balance sheet
Total assets
$88.72B
Total liabilities
$83.37B
Debt
$61.6B
Equity
$5.35B
Working capital
$30.49B
Liquidity
Debt to equity
11.52
Current ratio
3.14
Quick ratio
2.62
Net debt/EBITDA
2.11
Margins
EBITDA margin
54.4%
Gross margin
74.9%
Net margin
30.2%
Operating margin
34.3%
Efficiency
Return on assets
11.4%
Return on equity
210%
Return on invested capital
19.4%
Return on capital employed
14.5%
Return on sales
41.1%
Dividend
Dividend yield
3.69%
DPS
$8.14
Payout ratio
55%

AMGN stock price

How has the Amgen stock price performed over time
Intraday
0.97%
1 week
-0.3%
1 month
-7.96%
1 year
-14.06%
YTD
-15.99%
QTD
-8.73%

Financial performance

How have Amgen's revenue and profit performed over time
Revenue
$26.19B
Gross profit
$19.63B
Operating income
$8.99B
Net income
$7.92B
Gross margin
74.9%
Net margin
30.2%
The net margin rose by 39% year-on-year and by 21% since the previous quarter
The net income has grown by 38% YoY and by 21% from the previous quarter
The company's operating margin rose by 13% YoY but it fell by 6% QoQ
AMGN's operating income is up by 12% year-on-year but it is down by 6% since the previous quarter

Growth

What is Amgen's growth rate over time

Valuation

What is Amgen stock price valuation
P/E
14.9
P/B
22.03
P/S
4.5
EV/EBIT
13.74
EV/EBITDA
10.39
EV/Sales
5.65
AMGN's EPS is up by 45% year-on-year and by 22% since the previous quarter
The P/E is 33% below the 5-year quarterly average of 22.2 and 22% below the last 4 quarters average of 19.1
Amgen's equity has increased by 46% from the previous quarter
The stock's price to book (P/B) is 41% less than its last 4 quarters average of 37.3 and 10% less than its 5-year quarterly average of 24.5
The P/S is 13% less than the 5-year quarterly average of 5.2 and 10% less than the last 4 quarters average of 5.0

Efficiency

How efficient is Amgen business performance
The ROE has soared by 121% YoY but it has contracted by 15% from the previous quarter
AMGN's return on sales is up by 40% year-on-year and by 24% since the previous quarter
AMGN's return on assets is up by 23% year-on-year and by 8% since the previous quarter
The ROIC has grown by 13% YoY and by 8% from the previous quarter

Dividends

What is AMGN's dividend history
DPS
$8.14
Dividend yield
3.69%
Payout ratio
55%
Recent dividends

Financial health

How did Amgen financials performed over time
Amgen's total assets is 6% more than its total liabilities
AMGN's quick ratio has surged by 191% year-on-year and by 176% since the previous quarter
Amgen's current ratio has soared by 123% from the previous quarter and by 118% YoY
AMGN's debt to equity has shrunk by 71% YoY but it is up by 8% QoQ
The debt has surged by 67% year-on-year and by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.